Stay updated on Nivolumab With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision has been updated to v3.4.3. The previous revision v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:30.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the older site-wide funding/status notice. No study content, eligibility criteria, or outcome measures were altered.
    Difference
    0.3%
    Check dated 2026-02-11T02:00:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice explains that due to a lapse in government funding, information on this site may not be up to date and that the NIH Clinical Center is open, with updates at cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:24:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows the glossary toggle and updated metadata, adding 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T21:33:31.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T17:40:02.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section now includes Texas; the old label 'Texas Locations' has been removed. Updated the footer to revision v3.3.3 and removed the 'HHS Vulnerability Disclosure' line.
    Difference
    0.2%
    Check dated 2025-12-23T08:20:03.000Z thumbnail image

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.